ENDRA Life Sciences (NASDAQ:NDRA) reported quarterly losses of $(0.05) per share which met the analyst consensus estimate. This is a 16.67 percent increase over losses of $(0.06) per share from the same period last year.
‘Lockheed Martin Delivers Its Highest Powered Laser To Date To U.S. Department Of Defense’ -Lockheed Martin
https://news.lockheedmartin.com/2022-09-15-Lockheed-Martin-Delivers-Its-Highest-Powered-Laser-to-Date-to-US-Department-of-Defense
BOTHELL, Wash., Sept. 15, 2022 – Lockheed Martin (NYSE:LMT)
